Denis S. Grankin

Denis S. Grankin

Auto-generated profile, based on publicly available information

Denis S. Grankin

Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации, Новосибирск

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2021 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
OVO.YA. Vasiltseva
O.YA. Vasiltseva
AEA.G. Edemskiy
A.G. Edemskiy
ДГД. С. Гранкин
Д. С. Гранкин
ЕКЕ. Н. Кливер
Е. Н. Кливер
АCАлександр Михайлович Chernyavskiy
Александр Михайлович Chernyavskiy
ОВО. Я. Васильцева
О. Я. Васильцева
Chronic thromboembolic pulmonary hypertension is a long-term consequence of acute pulmonary embolism. Gradual obstruction of the pulmonary arteries and secondary changes in the pulmonary microcirculation over time cause progressive increases in pulmonary vascular resistance and pulmonary artery pressure that can result in severe right heart failure. This article provides an overview of pulmonary embolism and chronic thromboembolic pulmonary hypertension scientific literature and national guidelines. We focus on disease and recurrence risk factors and outline future directions of research to improve short- and long-term patient outcomes.Received 17 January 2021. Revised 1 March 2021. Accepted 19 April 2021.Funding: The study did not have sponsorship.Conflict of interest: The authors declare no conflicts of interests.Contribution of the authorsConception and study design: A.M. Chernyavskiy, A.G. Edemskiy, D.S. Grankin, E.N. KliverDrafting the article: O.Ya. VasiltsevaCritical revision of the article: E.N. KliverFinal approval of the version to be published: O.Ya. Vasiltseva, A.G. Edemskiy, D.S. Grankin, E.N. Kliver, A.M. Chernyavskiy

4 March 2025 in Eurasian heart journal
Verified
Journal Article
Open access
PDF file
NDN. M. Danilov
N. M. Danilov
YMYu. G. Matchin
Yu. G. Matchin
DGD. S. Grankin
D. S. Grankin
NMN. V. Marukyan
N. V. Marukyan
SYS. Y. Yarovoy
S. Y. Yarovoy
СЯС. Ю. Яровой
С. Ю. Яровой
For a long time, the only method of revascularization in patients with chronic thromboembolic pulmonary hypertension (CTEPH) was pulmonary thromboendarterectomy from the branches of pulmonary artery. Transluminal balloon pulmonary angioplasty (BPA), as an alternative treatment option for inoperable and residual CTEPH, appeared recently, but has already firmly taken its place in the treatment algorithm of CTEPH, and has significantly improved the prognosis in such patients. Active use of BPA in everyday practice served as the reason for the creation of this consensus in order to summarize and systematize modern data on patient selection, technique and goals of endovascular treatment, prevention and treatment of complications. The document additionally covers the issues of visualization of the pulmonary arteries, complex variants of damage and describes an algorithm for the prevention and treatment of pulmonary injury after BPA. The recommendations provided in the consensus are based on the results of national and foreign studies, the experience of experts and are intended for specialists who are part of a multidisciplinary team for the management of patients with CTEPH (cardiologists, endovascular and cardiovascular surgeons), as well as pulmonologists, radiation diagnosticians and physicians.

3 June 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
YRYanina L. Rusakova
Yanina L. Rusakova
DGDenis S. Grankin
Denis S. Grankin
KPKseniya S. Podolskaya
Kseniya S. Podolskaya
IZIrina Y. Zhuravleva
Irina Y. Zhuravleva
Pigs as laboratory animals are used in preclinical studies aimed at developing medical devices for cardiac surgery. The anatomy of the cardiovascular system of these animals has been well studied and acknowledged as suitable for use and the testing of new cardiovascular devices developed for humans. However, there are no morphometric characteristics of the aortic root and thoraco-abdominal part of porcine aorta. This can lead to difficulties in experimental surgery and even result in the death of experimental animals due to the mismatch in the size of the implantable devices. Thus, such information is essential to enhance the efficiency of surgical technologies used for eliminating aortic pathologies in their various sections. The purpose of our research is to study the anatomy of the aorta in mini pigs and to assess whether the size, age, and sex of the animals affect the size of the main structures in their aortas. In addition, we attempted to compare the results obtained by transesophageal echocardiography (TEE) and angiography. We studied 28 laboratory mini pigs, dividing them into three groups by body weight (40–70 kg, 71–90 kg, and 90 kg). We did not find any relationship between the external somatometric characteristics of the animals and the size of their aortas. Animals have individual anatomical variability in their cardiovascular systems, which means that they need to be examined in terms of preoperative planning by any available method—echocardiography, angiography, or multispiral computed tomography (CT).

1 January 2022 in Профилактическая и клиническая медицина
Verified
Journal Article
Closed access
VKV.V. Khominets
V.V. Khominets
LKLidia I. Kalyuzhnaya
Lidia I. Kalyuzhnaya
AGA.S. Grankin
A.S. Grankin
RFR.F. Fedorov
R.F. Fedorov
DVDaniil Volov
Daniil Volov
AKA.V. Komarov
A.V. Komarov
Традиционные методики замещения костных дефектов в свое время продемонстрировали качественно новый подход к проблеме замещения костных дефектов. По мере их применения открылись некоторые отрицательные стороны традиционных методов и сегодня можно сделать вывод, что существующие традиционные методики замещения значимых дефектов костной ткани не в полной мере удовлетворяют клиницистов, поэтому необходим поиск новых перспективных методик, базирующихся на фундаментальных исследованиях процессов репаративного остеогенеза, некоторые из которых пересматриваются в последние годы. За последние годы накоплен достаточный массив фундаментальных открытий в области тканевой инженерии, которые позволяют рассматривать новые способы восстановления дефектов костной ткани для применения их в клинической практике. Анализ эволюции наиболее распространенных методов замещения костной ткани и поиск перспективных тканеинженерных решений. На основании анализа доступных научных публикаций сравнить современные методики замещения костных дефектов и определить наиболее перспективное направление для исследования и применения в клинической практике. Поиск полноценной альтернативы аутогенной костной ткани приводит к необходимости использования «неординарных» биологически активных материалов, обладающих высокой остеоиндуктивностью. Одной из перспективных методик, на наш взгляд, является использование внеклеточного матрикса из провизорных органов, который так же обладает высокой остеогенной активностью, но при этом безопасен в применении и относительно прост в...

1 November 2023 in Annals of the Russian academy of medical sciences
Verified
Journal Article
Open access
PDF file
ACAlexander M. Chernyavskiy
Alexander M. Chernyavskiy
AEAlexander G. Edemskiy
Alexander G. Edemskiy
OVOksana Y. Vasiltseva
Oksana Y. Vasiltseva
EKElena N. Kliver
Elena N. Kliver
DGDenis S. Grankin
Denis S. Grankin
ЕГЕдемский Александр Геннадьевич
Едемский Александр Геннадьевич
Chronic thromboembolic pulmonary hypertension is group IV of pulmonary hypertension, which develops with occlusive-stenotic lesions of the pulmonary artery after a pulmonary embolism. There are no clear data on the epidemiology of this disease. At the same time, it is obvious that it is much more widespread than is commonly believed. This is due to the nonspecific clinical picture and the lack of awareness of clinicians about this disease. On the one hand, the pathogenesis of CTEPH is well studied and in many respects similar to pulmonary arterial hypertension, on the other hand, it is not clear why blood clots do not dissolve in a certain percentage of patients. Diagnosis of chronic thromboembolic pulmonary hypertension is fairly well described and should be carried out according to a special algorithm. The treatment of choice is pulmonary endarterectomy. In inoperable patients and patients with residual pulmonary hypertension after surgery, it is possible to perform balloon angioplasty of the pulmonary artery and PAH-specific therapy. In our study, the safety and efficacy of a new method for the treatment of a residual form of chronic thromboembolic pulmonary hypertension, radiofrequency denervation of the pulmonary artery, has been proven. The pathogenetic basis of this technique is the desympathization of the pulmonary circulation by radiofrequency destruction of the autonomic ganglia of the bifurcation of the pulmonary artery and the interruption of the so-called pulmo-pulmonary reflex.

8 November 2024 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
ABA.G. Badoian
A.G. Badoian
DGD.S. Grankin
D.S. Grankin
OKO.V. Krestyaninov
O.V. Krestyaninov
USU.SH. Sharafutdinov
U.SH. Sharafutdinov
SMS.N. Manukian
S.N. Manukian
DKDmitrii Khelimskii
Dmitrii Khelimskii
Background: Data on the short-term efficacy and safety of balloon pulmonary angioplasty (BPA) in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) are widely presented in the world literature; meanwhile information on long-term patient outcomes is very limited. Objective: The study aimed at the assessing of the short- and long-term results of balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension who completed all BPA sessions. Methods: We conducted a retrospective data analysis on 144 patients with a diagnosis of CTEPH who have completed BPA series in the common center from August 2015 through April 2023. Clinical and procedural results including the data from right heart catheterization, as well as long-term outcomes were collected and evaluated. Nonparametric rank sum tests were used to assess changes in hemodynamic parameters of the pulmonary artery before and after BPA. Survival analysis was performed using the Kaplan-Meier method: the impact of individual and procedure-related factors on the occurrence of death in the long-term follow-up period was assessed with univariate and multivariate logistic regressions. Results: A total of 446 BPA sessions were performed across 144 patients. The median value of mean pulmonary artery pressure (mPAP) decreased significantly by 9 mmHg (from 41 to 32). Out of 446 BPA sessions, there were 4 periprocedural deaths (0.9% of the number of procedures and 2.7% of the number of patients). Of the 134 patients available for contact, 26 (19.4%) died in the long-term period. Overall, 1- and 3- year survival probabilities were 93% and 82%, respectively. Multivariable logistic regression analysis showed that the chronic obstructive pulmonary disease (OR: 7.8 (1.86, 36.7), p = 0.006), coronary artery disease (OR: 3.78 (1.28, 11.2), p = 0.02) and a smaller decrease of mPAP after last BPA (OR: 0.91 (0.86, 0.97), p = 0.003) were independently associated with a death at follow-up period. Additional receiver operating characteristic (ROC) analysis revealed that a change in mPAP by 4.5 mmHg was the most effective predictor of death at follow-up with sensitivity and specificity equal to 0.68 and 0.60, respectively. Conclusion: Balloon pulmonary angioplasty in patients with CTEPH is a safe procedure with significant enhancement of pulmonary hemodynamics but long-term results remain still unsatisfactory that emphasizes the complexity of this cohort of patients and the demand for developing algorithms for their treatment and monitoring. Received 26 June 2024. Revised 26 July 2024. Accepted 1 October 2024. Funding The study did not have sponsorship. Conflict of interest The authors declare no conflict of interest. Contribution of the authorsConception and study design: A.G. Badoian, O.V. KrestyaninovData collection and analysis: A.G. Badoian, U.Sh. Sharafutdinov, S.N. ManukianStatistical analysis: A.G. Badoian, A.A. BaranovDrafting the article: A.G. Badoian, A.A. Baranov, D.A. Khelimskii, D.S. GrankinCritical revision of the article: O.V. Krestyaninov, D.S. GrankinFinal approval of the version to be published: A.G. Badoian, D.S. Grankin, O.V. Krestyaninov, U.Sh. Sharafutdinov, S.N. Manukian, A.A. Baranov, D.A. Khelimskii